BioRestorative Therapies
Stock Forecast, Prediction & Price Target
BioRestorative Therapies Financial Estimates
BioRestorative Therapies Revenue Estimates
BioRestorative Therapies EBITDA Estimates
BioRestorative Therapies Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $46K N/A | $119.8K 160.43% | $145.8K 21.70% | Avg: $1.18M Low: $284.4K High: $2.08M avg. 712.75% | Avg: $1.46M Low: $351.96K High: $2.58M avg. 23.75% | Avg: $46.86M Low: $11.24M High: $82.49M avg. 3096.01% | Avg: $94.85M Low: $22.76M High: $166.95M avg. 102.38% |
Net Income
% change YoY
| $-29.93M N/A | $-18.01M 39.82% | $-10.41M 42.17% | Avg: $-21.43M Low: $-10.54M High: $-7.76M avg. -105.73% | Avg: $-26.02M Low: $-8.64M High: $-5.77M avg. -21.43% | Avg: $3.71M Low: $44.54K High: $7.37M avg. 114.26% | Avg: $9.91M Low: $118.95K High: $19.70M avg. 167.04% |
EBITDA
% change YoY
| $-42.39M N/A | $-18.99M 55.20% | $-15.05M 20.73% | Avg: $-1.18M Low: $-2.08M High: $-284.4K avg. 92.12% | Avg: $-1.46M Low: $-2.58M High: $-351.96K avg. -23.75% | Avg: $-46.86M Low: $-82.49M High: $-11.24M avg. -3096.01% | Avg: $-94.85M Low: $-166.95M High: $-22.76M avg. -102.38% |
EPS
% change YoY
| -$25.21 N/A | -$4.98 80.24% | -$2.47 50.40% | Avg: -$2.17 Low: -$2.5 High: -$1.84 avg. 12.14% | Avg: -$1.71 Low: -$2.05 High: -$1.37 avg. 21.19% | Avg: $0.88 Low: $0.01 High: $1.75 avg. 151.46% | Avg: $2.35 Low: $0.03 High: $4.67 avg. 167.04% |
Operating Expenses
% change YoY
| $26.35M N/A | $18.98M -27.96% | $15.36M -19.05% | Avg: $199.47M Low: $47.87M High: $351.07M avg. 1198.11% | Avg: $246.86M Low: $59.24M High: $434.47M avg. 23.75% | Avg: $7.88B Low: $1.89B High: $13.88B avg. 3096.01% | Avg: $15.96B Low: $3.83B High: $28.10B avg. 102.38% |
FAQ
What is BioRestorative Therapies stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 38.53% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -10.54M, average is -21.43M and high is -7.76M.
What is BioRestorative Therapies stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 983.72% in 2025-2028.
We have gathered data from 1 analysts. Their low revenue estimate is $284.4K, average is $1.18M and high is $2.08M.
What is BioRestorative Therapies stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 87.96% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.5, average is -$2.17 and high is $-1.84.